ElevateBio

About:

ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.

Twitter/X: elevatebio

Top Investors: Fidelity, Invus, Novo Nordisk, Vertex Ventures, Samsara BioCapital

Description:

ElevateBio is an operator of a portfolio of cell and gene therapy companies intended to develop, manufacture, and commercialize life-transforming medicines. The company creates a portfolio through partnerships with the world's innovative scientists and inventors as well as it created a centralized facility that integrates all the elements that translate cell and gene therapy R&D into commercially viable therapies quickly and efficiently, enabling patients to get medical products to treat severe diseases. Vikas Sinha, Mitchell Finer, and David Hallal co-founded ElevateBio in Cambridge, Massachusetts in 2017.

Total Funding Amount:

$1.25B

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)elevate.bio

Founders:

David Hallal, Mitchell Finer, Vikas Sinha

Number of Employees:

251-500

Last Funding Date:

2023-05-24

IPO Status:

Private

Industries:

Alternative Medicine

Biotechnology

Information Technology